Reid IR and Ibbertson HK. Calcium supplements in the prevention of steroid-induced osteoporosis.
Am J Clin Nutr.
1986;44:287-290.
Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis.
Cochrane Database Syst Rev.
1998;(1). DOI: 10.1002/14651858.CD000952.
Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D
3
supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
125: 961-968, 1996.
Davis RH, Parker WL, and Murdoch DP.
Aloe vera
as a biologically active vehicle for hydrocortisone acetate.
J Am Podiatric Med Assoc.
1991;81:1-9.
Teelucksingh S, Mackie ADR, Burt D, et al. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid.
Lancet.
1990;335:1060-1063.
Tamura Y, Nishikawa T, Yamada K, et al. Effects of glycyrrhetinic acid and its derivatives on delta-4-5-alpha- and 5-beta-reductase in rat liver.
Arzneimittelforschung.
1979;29:647-649.
Chen MF, Shimada F, Kato H, et al. Effect of glycyrrhizin on the pharmacokinetics of prednisolone following low dosage of prednisolone hemisuccinate.
Endocrinol Jpn.
1190;37:331-341.
Kumagai A, Nanaboshi M, Asanuma Y, et al. Effects of glycyrrhizin on thymolytic and immunosuppressive action of cortisone.
Endocrinol Jpn.
1967;14:39-42.
Robinzon B and Cutulo M. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?
Rheumatology.
1999;38:488-495.
van Vollenhoven RF, Park JL, Genovese MC, et al. A double-blind, placebo-controlled, clinical trial of dehydroepianodrosterone in severe systemic lupus erythematosus.
Lupus.
1999;8:181-187.
Ravina A, Slezak L, Mirsky N, et al. Reversal of corticosteroid-induced diabetes mellitis with supplemental chromium.
Diabet Med.
1999;16:164-167.
Ravina A, Slezak L, Mirsky N, et al. Control of steroid-induced diabetes with supplemental chromium.
J Trace Elem Exp Med.
1999;12:375-378.
Agnusdei D and Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety.
Calcif Tissue Int.
1997;61(suppl 1):S23-S27.
Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA.
2001;285:1482-1488.
Roy BD, Bourgeois JM, Mahoney DJ, et al. Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats.
Can J Physiol Pharmacol. 2002;80:1008-1014.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.